Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TELA Bio (TELA) Operating Margin (2018 - 2025)

TELA Bio has reported Operating Margin over the past 8 years, most recently at 91.05% for Q4 2025.

  • Quarterly results put Operating Margin at 91.05% for Q4 2025, down 971.0% from a year ago — trailing twelve months through Dec 2025 was 10.1% (up 141.0% YoY), and the annual figure for FY2025 was 10.1%, up 141.0%.
  • Operating Margin for Q4 2025 was 91.05% at TELA Bio, up from 36.51% in the prior quarter.
  • Over the last five years, Operating Margin for TELA hit a ceiling of 100.76% in Q4 2024 and a floor of 123.69% in Q1 2021.
  • Median Operating Margin over the past 5 years was 72.07% (2023), compared with a mean of 59.64%.
  • Biggest five-year swings in Operating Margin: surged 17300bps in 2024 and later crashed -2748bps in 2025.
  • TELA Bio's Operating Margin stood at 91.4% in 2021, then grew by 11bps to 81.22% in 2022, then rose by 11bps to 72.23% in 2023, then skyrocketed by 240bps to 100.76% in 2024, then decreased by -10bps to 91.05% in 2025.
  • The last three reported values for Operating Margin were 91.05% (Q4 2025), 36.51% (Q3 2025), and 44.96% (Q2 2025) per Business Quant data.